Clinical Trial

First in Man Study of Pulsed Field Ablation System for the Treatment of Paroxysmal Atrial Fibrillation in 1 Patient

Completed
View on ClinicalTrials.gov →
Summary
This is the first in man study of CadioPulseTM ( pulsed field ablation system) developed and manufactured by Hangzhou Dinova EP Technology Co., Ltd, which can be used for Pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation. This study aims to initially verify the safety and efficacy of the device.
Trial Details
NCT Number NCT07452211
Lead Sponsor Hangzhou Dinova EP Technology Co., Ltd
Conditions Paroxysmal Atrial Fibrillation (PAF)
Enrollment 10 participants
Start Date 2020-12-18
Primary Completion 2022-04-10 (estimated)
Study Completion 2022-04-10 (estimated)
Updated on ClinicalTrials.gov 2026-03-05